Global NSAIDs Market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 8.2 billion by 2030 from USD 7.1 billion in 2018. The market is driven by factors such as increasing prevalence of chronic pain and arthritis, rising awareness about the benefits of NSAIDs, and growing demand for over-the-counter drugs among consumers. However, high cost associated with NSAIDs may hamper the growth of this market during the forecast period. The global NSAID market is segmented on the basis of type into aspirin, ibuprofen, naproxen and nabumetone; application into back pain treatment and osteoarthritis treatment; and region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA). Among these segments, NA accounted for a major share in 2018 owing to its large population base as well as high prevalence rates for chronic pain conditions such as arthritis among adults in this region. -The global population is aging, which will lead to an increase in the number of people with chronic pain and arthritis. -The global population is also growing, which will lead to an increase in the number of people with chronic pain and arthritis.
Industry Growth Insights published a new data on “NSAIDs Market”. The research report is titled “NSAIDs Market research by Types (Aspirin, Ibuprofen, Naproxen, Nabumetone, Others), By Applications (Back Pain Treatment, Osteoarthritis Treatment, Other Disease Treatment), By Players/Companies Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, GlaxoSmithKline, Reddy Pharmaceuticals, Verywell”.
Scope Of The Report
Report Attributes
Report Details
Report Title
NSAIDs Market Research Report
By Type
Aspirin, Ibuprofen, Naproxen, Nabumetone, Others
By Application
Back Pain Treatment, Osteoarthritis Treatment, Other Disease Treatment
By Companies
Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, GlaxoSmithKline, Reddy Pharmaceuticals, Verywell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global NSAIDs Market Report Segments:
The global NSAIDs market is segmented on the basis of:
Types
Aspirin, Ibuprofen, Naproxen, Nabumetone, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Back Pain Treatment, Osteoarthritis Treatment, Other Disease Treatment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Novacap
- Abbott
- Pfizer
- Johnson & Johnson
- Cigna
- Geri-Care Pharmaceuticals
- Perrigo Company
- Kopran
- Merck Sharp & Dohme
- Sun Pharmaceutical Industries
- GlaxoSmithKline
- Reddy Pharmaceuticals
- Verywell
Highlights of The NSAIDs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aspirin
- Ibuprofen
- Naproxen
- Nabumetone
- Others
- By Application:
- Back Pain Treatment
- Osteoarthritis Treatment
- Other Disease Treatment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NSAIDs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NSAIDs are a type of medication that helps reduce inflammation and pain. They are often used to treat conditions such as arthritis, menstrual cramps, and headaches.
Some of the major players in the nsaids market are Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, GlaxoSmithKline, Reddy Pharmaceuticals, Verywell.
The nsaids market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. NSAIDs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. NSAIDs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. NSAIDs Market - Supply Chain
4.5. Global NSAIDs Market Forecast
4.5.1. NSAIDs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. NSAIDs Market Size (000 Units) and Y-o-Y Growth
4.5.3. NSAIDs Market Absolute $ Opportunity
5. Global NSAIDs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. NSAIDs Market Size and Volume Forecast by Type
5.3.1. Aspirin
5.3.2. Ibuprofen
5.3.3. Naproxen
5.3.4. Nabumetone
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global NSAIDs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. NSAIDs Market Size and Volume Forecast by Application
6.3.1. Back Pain Treatment
6.3.2. Osteoarthritis Treatment
6.3.3. Other Disease Treatment
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global NSAIDs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. NSAIDs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global NSAIDs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. NSAIDs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global NSAIDs Demand Share Forecast, 2019-2026
9. North America NSAIDs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America NSAIDs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America NSAIDs Market Size and Volume Forecast by Application
9.4.1. Back Pain Treatment
9.4.2. Osteoarthritis Treatment
9.4.3. Other Disease Treatment
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America NSAIDs Market Size and Volume Forecast by Type
9.7.1. Aspirin
9.7.2. Ibuprofen
9.7.3. Naproxen
9.7.4. Nabumetone
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America NSAIDs Demand Share Forecast, 2019-2026
10. Latin America NSAIDs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America NSAIDs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America NSAIDs Market Size and Volume Forecast by Application
10.4.1. Back Pain Treatment
10.4.2. Osteoarthritis Treatment
10.4.3. Other Disease Treatment
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America NSAIDs Market Size and Volume Forecast by Type
10.7.1. Aspirin
10.7.2. Ibuprofen
10.7.3. Naproxen
10.7.4. Nabumetone
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America NSAIDs Demand Share Forecast, 2019-2026
11. Europe NSAIDs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe NSAIDs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe NSAIDs Market Size and Volume Forecast by Application
11.4.1. Back Pain Treatment
11.4.2. Osteoarthritis Treatment
11.4.3. Other Disease Treatment
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe NSAIDs Market Size and Volume Forecast by Type
11.7.1. Aspirin
11.7.2. Ibuprofen
11.7.3. Naproxen
11.7.4. Nabumetone
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe NSAIDs Demand Share, 2019-2026
12. Asia Pacific NSAIDs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific NSAIDs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific NSAIDs Market Size and Volume Forecast by Application
12.4.1. Back Pain Treatment
12.4.2. Osteoarthritis Treatment
12.4.3. Other Disease Treatment
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific NSAIDs Market Size and Volume Forecast by Type
12.7.1. Aspirin
12.7.2. Ibuprofen
12.7.3. Naproxen
12.7.4. Nabumetone
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific NSAIDs Demand Share, 2019-2026
13. Middle East & Africa NSAIDs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa NSAIDs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa NSAIDs Market Size and Volume Forecast by Application
13.4.1. Back Pain Treatment
13.4.2. Osteoarthritis Treatment
13.4.3. Other Disease Treatment
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa NSAIDs Market Size and Volume Forecast by Type
13.7.1. Aspirin
13.7.2. Ibuprofen
13.7.3. Naproxen
13.7.4. Nabumetone
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa NSAIDs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global NSAIDs Market: Market Share Analysis
14.2. NSAIDs Distributors and Customers
14.3. NSAIDs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novacap
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cigna
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Geri-Care Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Perrigo Company
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Kopran
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merck Sharp & Dohme
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sun Pharmaceutical Industries
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GlaxoSmithKline
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Reddy Pharmaceuticals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Verywell
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook